A CATALYST FOR GROWTH

Dr. Satya Vadlamani Is The Chairperson And Managing Director Of Murali Krishna Pharma Pvt. Ltd. (Mkppl) – A Novel Drug Delivery Systems Company In Maharashtra, India. With Her Resolute Determination And Commitment To Succeed, She Has Revolutionised The Indian Pharma Landscape, Positively Impacting Countless Lives. Holding A Degree In Electrical And Electronics Engineering, Dr. Vadlamani Brings To The Table Almost 30 Years Of Invaluable Experience In Global Marketing Of Pharmaceutical Products. Her Visionary Leadership Has Propelled Mkppl To Unprecedented Heights, Making It One Of The Important Players In The Industry

Recent Awards

About us

DR. SATYA VADLAMANI

Dr. Satya Vadlamani Is The Chairperson And Managing Director Of Murali Krishna Pharma Pvt. Ltd. (Mkppl) – A Novel Drug Delivery Systems Company In Maharashtra, India. With Her Resolute Determination And Commitment To Succeed, She Has Revolutionised The Indian Pharma Landscape, Positively Impacting Countless Lives. Holding A Degree In Electrical And Electronics Engineering, Dr. Vadlamani Brings To The Table Almost 30 Years Of Invaluable Experience In Global Marketing Of Pharmaceutical Products. Her Visionary Leadership Has Propelled Mkppl To Unprecedented Heights, Making It One Of The Important Players In The Industry

Recent Blogs

Leadership in Pharma: Dr. Satya Vadlamani’s Vision Reflected at CPhI

Leadership in Pharma: Dr. Satya Vadlamani’s Vision Reflected at CPhI

Strong leadership shapes the pharmaceutical industry’s future, driving innovation that saves millions of lives worldwide. Dr. Satya Vadlamani, Managing Director of Murli Krishna Pharma Pvt. Ltd. (MKPPL), […]

Why CPhI Matters: Driving Innovation and Collaboration in the Pharma Sector

Why CPhI Matters: Driving Innovation and Collaboration in the Pharma Sector

The pharmaceutical industry relies on connections, partnerships, and shared innovation to bring life-saving medicines to patients worldwide. CPhI (Convention on Pharmaceutical Ingredients) stands as the most important […]

The Global Pharmaceutical Landscape: Insights from CPhl and Murli Krishna Pharma’s Vision

The Global Pharmaceutical Landscape: Insights from CPhl and Murli Krishna Pharma’s Vision

The global pharmaceutical industry is seeing tremendous changes in 2025, highlighted by advancements set to be presented at CPhI Frankfurt (Oct 28-30), and the innovative vision of […]